Advertisements


VistaGen Therapeutics issued two key U.S. patents covering AV-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

VistaGen Therapeutics Reports Fiscal Year 2018 Financial Results and Provides Year-to-Date Highlights

AV-101, VistaGen's Oral NMDA Receptor Modulator, Granted FDA Fast-Track Designation for Major Depressive Disorder Key AV-101 Patents Issued .....»»

Category: earningsSource: benzingaJun 26th, 2018

uniQure issued new patents covering methods of treating coagulopathies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 29th, 2018

VistaGen Therapeutics receives notice of allowance from USPTO for PH10 patent

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 13th, 2019

VistaGen Therapeutics Reports Fiscal 2019 Third Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2019 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ:VTGN), a clinical-stage biopharmaceutical company developing .....»»

Category: earningsSource: benzingaFeb 12th, 2019

VistaGen Therapeutics announces AV-101 stimulates formation of new brain cells

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2019

VistaGen Therapeutics management to meet with William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 29th, 2019

The World’s 50 Most Innovative Companies

The U.S. Patent and Trademark Office issued more than 300,000 utility patents in 2018. Though anyone can apply for a patent, large corporations tend to receive the most — more than one-fourth........»»

Category: blogSource: 247wallstJan 24th, 2019

Sparton issued two U.S. patents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2019

IBM Tops 2018 US Patents With 9100

IBM was issued more patents in 2018 by the U.S. Patent and Trademark Office than any other company. IBM claims that 2018 was the 26th year it held the top of the list by number of U.S.-issued patents......»»

Category: blogSource: 247wallstJan 8th, 2019

North Texas biotech settles litigation over ADHD drug

Grand Prairie-based Neos Therapeutics Inc. entered into a confidential settlement and licensing agreement with Teva Pharmaceuticals USA Inc. to resolve all ongoing litigation involving Neos' patents for its Cotempla product. The two companies got .....»»

Category: topSource: bizjournalsDec 27th, 2018

VistaGen Therapeutics receives Hong Kong patent for AV-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 29th, 2018

Clovis issued second U.S. patent covering rucaparib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 20th, 2018

VistaGen Therapeutics receives notices of allowance from IP Australia, JPO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 12th, 2018

VistaGen Therapeutics acquires license, worldwide rights to PH10 from Pherin

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 25th, 2018

Microsoft joins OIN with portfolio of 60,000 issued patents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 10th, 2018

Mid-Afternoon Market Update: Crude Oil Rises 1.75%; VistaGen Therapeutics Shares Spike Higher

Toward the end of trading Wednesday, the Dow traded up 0.60 percent to 26,935.16 while the NASDAQ climbed 0.66 percent to 8,052.12. The S&P also rose, gaining 0.47 percent to 2,937.25. read more.....»»

Category: blogSource: benzingaOct 3rd, 2018

VistaGen Therapeutics announces FDA fast track designation for AV-101

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2018

VistaGen shares surge 13% after FDA grants fast track status to non-opioid pain treatment

VistaGen Therapeutics Inc.'s stock surged 13% in premarket trade Wednesday, after the company said it h.....»»

Category: topSource: marketwatchOct 3rd, 2018

VistaGen Therapeutics, Pherin Pharmaceuticals announce license agreement

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

The Most Innovative Company By Patents: Old Tech Is #1

The most innovative companies, states and countries in the world In June, the United States Patent and Trademark Office issued its 10 mil.....»»

Category: blogSource: valuewalkSep 12th, 2018